Effect of GEMS-H on Locomotor Function in Adults
Launched by SAMSUNG ELECTRONICS · May 22, 2019
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
The GEMS-H is a hip-type assist device developed by Samsung Electronics. The GEMS-H is worn around the waist and fastened at the waist and thighs by a set of belts with velcro to assist motion at the hip joints. The device weighs 2.1kg, and has 2 brushless direct current motors running on a rechargeable lithium ion battery. The normal operation time for the device is 2 hours. It is controlled through a custom built application on a hand held tablet.
The purpose of this study is to investigate the effect of training with the Gait Enhancing and Motivating System-Hip (GEMS-H) vs. training wit...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: 19 - 84 years
- • No history of central nervous system related disease
- Exclusion Criteria:
- • Difficulty in walking due to conditions such as poor vision or fractures
- • Height is less than 140cm or more than 185cm.
- • Body mass index (BMI) greater than 35.
- • Difficulty understanding and participating in the study such as those with cognitive problems or dementia.
- • Subject who is at risk of falling during walking due to severe dizziness
About Samsung Electronics
Samsung Electronics is a global leader in technology and innovation, committed to enhancing the quality of life through advanced electronic solutions. With a strong emphasis on research and development, Samsung actively engages in clinical trials to explore and validate cutting-edge health technologies and medical devices. The company's dedication to rigorous scientific standards and collaboration with healthcare professionals aims to drive progress in digital health, diagnostics, and therapeutic interventions, ultimately contributing to improved patient outcomes and the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Yun-Hee Kim, MD, PhD
Principal Investigator
Samsung Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials